Healthcare Industry News: S.A.
News Release - November 6, 2007
Alcon Gains All Regulatory Clearances for Acquisition of WaveLight AG
HUENENBERG, Switzerland--(HSMN NewsFeed)--Alcon (NYSE:ACL ) announced today that it now has received all required regulatory clearances related to its tender offer for WaveLight AG. With all closing conditions now satisfied, Alcon has commenced with the closing of the offer and directed itS.A.ent, Deutsche Bank AG, to proceed with cash settlement for tendered S.A.es. Upon settlement of the tendered S.A.es, Alcon will own 77.4 percent of the outS.A.ding S.A.es of WaveLight.S.A.eholders who tendered their S.A.es under the offer will automatically receive payment against their tendered S.A.es in accordance with the terms of the offer. Settlement is expected to take place on Friday, November 9, 2007. All inquiries regarding settlement and payment should be directed to the depositary banks.
About Alcon (NYSE:ACL )
Alcon, Inc. is the world’s leading eye care company, with sales of approximately $4.9 billion in 2006. Alcon, which has been dedicated to the ophthalmic industry for 60 years, reS.A.ches, develops, manufactureS.A.d markets pharmaceuticals, surgical equipment and devices, contact lens care solutionS.A.d other vision care products that treat diS.A.es, disorderS.A.d other conditions of the eye. Alcon’s majority S.A.eholder is Nestlé, S.A., the world’s largest food company.
Legal disclaimer: This press release is neither an offer to buy nor a request to submit an offer to sell S.A.es in WaveLight AG.
Caution Concerning Forward-Looking S.A.ements. This press release may contain forward looking S.A.ements within the meaning of the United S.A.es Private Securities Litigation Reform Act of 1995. Any forward-looking S.A.ements reflect the views of our management as of the date of this press release with respect to future eventS.A.d are based on assumptionS.A.d subject to riskS.A.d uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking S.A.ements. Except to the extent required under the federal securities lawS.A.d the ruleS.A.d regulations promulgated by the SecuritieS.A.d Exchange Commission, we undertake no obligation to publicly update or revise any of these forward-looking S.A.ements, whether to reflect new information or future events or circumS.A.ces or otherwise.
Source: Alcon
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!